维普期刊资源整合服务平台（V6.5）

152篇 您的检索式：作者名="KONSTAM MA"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction显示文摘	Wang NC Maggioni AP Konstam MA	2008	JAMA2008，99，22：	1
2	Short term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials显示文摘	Gheorghiade M Konstam MA Burnett JC Jr	2007	JAMA2007，297，12：	1
3	Effects of lasartan and captopril on left ventricular volumes in elderly patients with heart failure:results of the ELITE ventricular function substudy 显示文摘	Konstam MA Patten RD Thomas I	2000	Am Heart J2000，139，：	1
4	Short term clinical effects of tolvaptan,an oral vasopressin antagonist,in patients hospitalized for heart failure: results of the EVEREST clinical status trials显示文摘	Gheorghiade M Konstam MA Burnett JC	2007	JAMA2007，297，12：	1
5	Effects of oral tolvaptan in patients hospitalized for worsening heart {ailure: the EVEREST Outcome Trial显示文摘	Gheorghiade M Konstam MA Burnett JC Jr	2007	JAMA2007，297，12：	1
6	Cardiovascular thrombotic events in controlled,clinical trial of rofecoxib显示文摘	KONSTAM MA WEIR MR REICIN A	2001	Circulation2001，104，19：	1
7	Role of angiotensin converting enzyme inhibitors in preventing left ventricular remodeling following myocardial infarction显示文摘	Konstam MA		0，，：	1
8	Short term clinical effects of tolvaptan,an oral vasopressin antagonist,in patients hospitalized for heart failure:the EVEREST clinical status trials显示文摘	Gheorghiade M Konstam MA Burnett JC	2007	JAMA2007，，297：	1
9	Effects of oral tolvaptan in patients hospitalized for worsening heart failure:the EVEREST Outcome Trial显示文摘	Konstam MA Gheorghiade M Burnett JC Jr	2007	JAMA2007，297，2：	1
10	Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators 显示文摘	KONSTAM MA GHEORGHIADE M BURNETT JC	2007	JAMA2007，297，12：	1
11	Thrombus imaging in a primate model with antibodies specific for an external membrane protein of activated platelets 显示文摘	Balabrica TM Furie BC Konstam MA	1989	Proc Natl Acad Sci USA1989，86，：	1
12	Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment显示文摘	Konstam MA Kramer DG Pate/ AR	2011	J Am Co]l Cardiol Cardiovasc Imaging2011，4，：	1
13	Pharmacotherapy for systolic dysfunction: a review of randomized clinical trial 显示文摘	Benatar D Konstam MA	1997	Am J1997，80，8：	1
14	Effectiveness of preload reserve as determinant of clinical status in patients with left ventricular systolic dysfunction显示文摘	Konstam MA Kronenbery MW Udelson JE	1990	Am J Cardiol1990，69，：	1
15	Cause and management of heart failure in patients with Chronic renal disease 显示文摘	AI - Ahmand A Samak M J Salem DN Konstam MA	2001	Semin Nephol2001，21，1：	1
16	Home monitoring should be the central element in an effective program of heart failure disease management 显示文摘	Konstam MA	2012	Circulation2012，125，：	1
17	Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE)显示文摘	Packer M Califf RM Konstam MA	2002	Circulation2002，106，8：	1
18	Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial显示文摘	Konstam MA Gheorghiade M Bumett JC	2007	JAMA2007，297，12：	1
19	Effects of oral tolvaptan in patients hospitalized for worsening heart failure:the EVEREST Outcome Trial 显示文摘	Konstam MA Cheorghiade M Burnaett JC	2007	JAMA2007，297，12：	1
20	Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials显示文摘	Cheorghiade M Konstam MA Burnett JC Jr	2007	JAMA2007，297，12：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示